Ticker Details
Verve Therapeutics, Inc.
IPO Date:	July 17, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$994.04M
Activated in VL:	False

Average Daily Range
Avg Daily Range:	$0.78 | 3.84%
Avg Daily Range (30 D):	$0.05 | 0.41%
Avg Daily Range (90 D):	$0.16 | 3.21%

Institutional Daily Volume
Avg Daily Volume:	1.12M
Avg Daily Volume (30 D):	1.9M
Avg Daily Volume (90 D):	4M

Trade Size
Avg Trade Size (Sh.):	91
Avg Trade Size (Sh.) (30 D):	248
Avg Trade Size (Sh.) (90 D):	168

Institutional Trades
Total Institutional Trades:	1,587
Avg Institutional Trade:	$2.1M
Avg Institutional Trade (30 D):	$4.11M
Avg Institutional Trade (90 D):	$2.33M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.54M
Avg Closing Trade (30 D):	$8.79M
Avg Closing Trade (90 D):	$3.29M
Avg Closing Volume:	174.61K

News

Jun 20, 2025 @ 2:57 PM SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Invest... Source: N/A

Jun 17, 2025 @ 12:07 PM Eli Lilly Expands Into Gene Editing With Verve The... Source: Vandana Singh

May 28, 2025 @ 11:00 AM Verve Therapeutics to Participate in Upcoming Inve... Source: N/A

May 19, 2025 @ 2:56 PM Bio/Pharmaceutical Outsourcing Report, March 2025 ... Source: Researchandmarkets.Com

Apr 18, 2025 @ 10:36 PM Why Verve Therapeutics Zoomed 40% Higher This Week... Source: Eric Volkman

Financials
	TTM	Q1 2025	Q4 2024
Basic EPS	$-2.11	$-.35	$-.58
Diluted EPS	$-2.11	$-.35	$-.58
Revenue	$59.61M	$32.98M	$13.08M
Gross Profit
Net Income / Loss	$-181.01M	$-31.03M	$-50.04M
Operating Income / Loss	$-208.45M	$-36.64M	$-56.07M
Cost of Revenue
Net Cash Flow	$-47.65M	$-76.01M	$13.85M
PE Ratio